Enfortumab vedotin-ejfv
Product Specifications
CAS Number
1346452-25-2
Specifications
3.6
Synonyms
Padcev
Target
Antibody-Drug Conjugate
Applications
Others
Additionnal Information
Enfortumab vedotin-ejfv (Padcev) is an antibody-drug conjugate (ADC) composed of an fully human anti-Nectin-4 IgG1 kappa monoclonal antibody (AGS-22C3), conjugated to Monomethyl Auristatin E (MMAE), via a protease-cleavable maleimidocaproyl-valyl-citrullinyl-p-aminobenzyloxycarbonyl. Enfortumab vedotin-ejfv has the potential for use in research of urothelial carcinoma.
Storage Conditions
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
CSB-EP006163HU1-01 20 µg
Recombinant Human Cytotoxic T-lymphocyte protein 4 (CTLA4), partial
Sign In for Pricing
View Details CSB-EP006163HU1-02 100 µg
Recombinant Human Cytotoxic T-lymphocyte protein 4 (CTLA4), partial
Sign In for Pricing
View Details CSB-EP006163HU1-03 1 mg
Recombinant Human Cytotoxic T-lymphocyte protein 4 (CTLA4), partial
Sign In for Pricing
View Details 
M2600-2HS 500 mL
Chondrocyte Growth Medium, Ready-to-Use, 500 ml, 2% Human Serum Supplement + Factors
Sign In for Pricing
View Details 
SC046 2x 10^6 Cell/mL - 1 mL
SH-SY5Y / RFP (Puromucin) stable cell line
Sign In for Pricing
View Details